IBRITUMOMAB TIUXETAN
N0000148737
http://purl.bioontology.org/ontology/NDFRT/N0000148737
I [Preparations]
4Q52C550XK
Ingredient
DRUG_KIND
Increased B Lymphocyte Destruction [PE]
Lymphoma, Follicular [Disease/Finding]
Drug Hypersensitivity [Disease/Finding]
Lymphoma, Low-Grade [Disease/Finding]
IBRITUMOMAB TIUXETAN Y-90 INJ,KIT [VA Product]
IBRITUMOMAB TIUXETAN IN-111 INJ,KIT [VA Product]
Lymphoma, B-Cell [Disease/Finding]
Lactation [Disease/Finding]
Pregnancy [Disease/Finding]
Neutropenia [Disease/Finding]
ibritumomab tiuxetan [Chemical/Ingredient]
Antibody-Surface Protein Interactions [MoA]
Increased Immunologically Active Molecule Degradation [PE]
Thrombocytopenia [Disease/Finding]
Immunologic Factor
Amino Acid, Peptide, or Protein
Pharmacologic Substance
Active
T121
T129
T116
C0877880
50.6^3758^
50.416^3973^
4021301